» Articles » PMID: 34924256

Deep Learning for Radiotherapy Outcome Prediction Using Dose Data - A Review

Overview
Specialty Oncology
Date 2021 Dec 20
PMID 34924256
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence, and in particular deep learning using convolutional neural networks, has been used extensively for image classification and segmentation, including on medical images for diagnosis and prognosis prediction. Use in radiotherapy prognostic modelling is still limited, however, especially as applied to toxicity and tumour response prediction from radiation dose distributions. We review and summarise studies that applied deep learning to radiotherapy dose data, in particular studies that utilised full three-dimensional dose distributions. Ten papers have reported on deep learning models for outcome prediction utilising spatial dose information, whereas four studies used reduced dimensionality (dose volume histogram) information for prediction. Many of these studies suffer from the same issues that plagued early normal tissue complication probability modelling, including small, single-institutional patient cohorts, lack of external validation, poor data and model reporting, use of late toxicity data without taking time-to-event into account, and nearly exclusive focus on clinician-reported complications. They demonstrate, however, how radiation dose, imaging and clinical data may be technically integrated in convolutional neural networks-based models; and some studies explore how deep learning may help better understand spatial variation in radiosensitivity. In general, there are a number of issues specific to the intersection of radiotherapy outcome modelling and deep learning, for example translation of model developments into treatment plan optimisation, which will require further combined effort from the radiation oncology and artificial intelligence communities.

Citing Articles

Deep learning combining imaging, dose and clinical data for predicting bowel toxicity after pelvic radiotherapy.

Elhaminia B, Gilbert A, Scarsbrook A, Lilley J, Appelt A, Gooya A Phys Imaging Radiat Oncol. 2025; 33:100710.

PMID: 40046574 PMC: 11880715. DOI: 10.1016/j.phro.2025.100710.


External validation of a multimodality deep-learning normal tissue complication probability model for mandibular osteoradionecrosis trained on 3D radiation distribution maps and clinical variables.

Humbert-Vidan L, Hansen C, Patel V, Johansen J, King A, Urbano T Phys Imaging Radiat Oncol. 2024; 32:100668.

PMID: 39563783 PMC: 11574792. DOI: 10.1016/j.phro.2024.100668.


Artificial intelligence uncertainty quantification in radiotherapy applications - A scoping review.

Wahid K, Kaffey Z, Farris D, Humbert-Vidan L, Moreno A, Rasmussen M Radiother Oncol. 2024; 201:110542.

PMID: 39299574 PMC: 11648575. DOI: 10.1016/j.radonc.2024.110542.


Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.

Deasy J Semin Radiat Oncol. 2024; 34(4):379-394.

PMID: 39271273 PMC: 11698470. DOI: 10.1016/j.semradonc.2024.07.012.


Integrating Deep Learning-Based Dose Distribution Prediction with Bayesian Networks for Decision Support in Radiotherapy for Upper Gastrointestinal Cancer.

Kim D, Jang B, Kim E, Chie E Cancer Res Treat. 2024; 57(1):186-197.

PMID: 39091147 PMC: 11729311. DOI: 10.4143/crt.2024.333.